Skip to main content
SpringerLink
Log in

Bladder-Conserving Therapy for Invasive Bladder Cancer Using Transurethral Surgery, Chemotherapy, and Radiation Therapy with Patient Selection by Initial Treatment Response

  • Chapter
Carcinoma of the Bladder

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 164 Accesses

Abstract

The Fourth International Consensus Meeting on Bladder Cancer provided updated results of conservative surgery, radiation therapy, and systemic chemotherapy, each as monotherapy, as well as strategies of combined modality treatment with two or three of these modalities as reviewed by a panel of nine urologic oncologists (K. Koiso, W.U. Shipley, S. Keuppen, L. Baert, R.R. Hall, M. Hudson, S. Khoury, Y. Kubota, and H. Van Poppel). Based on this review, ten areas of consensus were reached:

  1. 1.

    The primary goal of bladder preservation treatment for a patient with muscle-invading bladder cancer is survival; bladder preservation in the interest of quality of life is a secondary objective.

  2. 2.

    Only a small proportion of carefully selected patients may be cured by transurethral surgery alone or by partial cystectomy alone.

  3. 3.

    Radiation therapy is currently the standard bladder-preserving therapy against which all other bladder-preserving methods must be compared.

  4. 4.

    Systemic chemotherapy as monotherapy is inadequate and cannot be recommended.

  5. 5.

    The addition of cisplatin-containing systemic chemotherapy to radiation therapy or conservative surgery appears to improve local control. Whilst no multimodality therapeutic regimen has yet been shown to be clearly optimal with regard to local efficacy and minimization of toxicity, monontherapy for bladder-preserving treatment is probably not desirable as a routine approach.

  6. 6.

    Deferring the patient from immediate cystectomy does not appear to compromise survival nor does the addition of primary systemic chemotherapy appear to increase significantly the morbidity of cystectomy or radiotherapy.

  7. 7.

    All patients treated by bladder-preserving therapy must return to the urologist for regular cystoscopic follow-up so that additional therapy may be started at the earliest opportunity, if relapse occurs.

  8. 8.

    Bladder substitution will always be second best and is suboptimal compared with a normally functioning disease-free bladder.

  9. 9.

    If alternatives to cystectomy are not considered, little progress will be made in the treatment of muscle-invading bladder cancer.

  10. 10.

    Randomized phase III trials will have to be performed to establish the role of optimal combined modality treatment for bladder preservation but patient recruitment to such trials may prove difficult unless urologists are prepared to open their minds to the possibility that cystectomy may not be the best treatment for all patients with muscle-invading bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Begg A (1990) Cisplatin and radiation: interaction probabilities and other therapeutic possibilities. Int J Radiat Oncol Biol Phys 19: 1183–1189

    Article  PubMed  CAS  Google Scholar 

  • Cervak J, Cufer T, Maroit F, et al. (1991) Combined chemotherapy and radiotherapy in muscle-invasive bladder carcinoma. Complete remission results. ECCO 6:Abstract #561

    Google Scholar 

  • Cole D, Durrant K, Robert J, et al. (1992) A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladder. Br J Radiol 65: 792–798

    Article  PubMed  CAS  Google Scholar 

  • DeNeve W, Lybeert ML, Goor C, et al. (1995) Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Radiother Oncol 36: 183–188

    Article  CAS  Google Scholar 

  • Dunst J, Sauer R, Schrott KM, et al. (1994) Organ-sparing treatment of advanced bladder cancer: a 10 year experience. Int J Radiat Oncol Biol Phys 30: 261–266

    Article  PubMed  CAS  Google Scholar 

  • Durand R, Vanderbyl S (1988) Response of cell populations in spheroids to radiation-drug combinations. NCI Monogr 6: 95–100

    PubMed  Google Scholar 

  • Farah R, Chodak GW, Vogelzang NI, et al. (1991) Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report). Int J Radiat Oncol Biol Phys 20: 413–417

    Article  PubMed  CAS  Google Scholar 

  • Flentje M, Eble M, Haner U (1991) Additive effects of cisplatin and radiation in human tumor cells under toxic conditions. Radiother Oncol 24: 60–63

    Article  Google Scholar 

  • Fung CY, Shipley WU, Young RH, et al. (1991) Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol 9: 1533–1542

    PubMed  CAS  Google Scholar 

  • Gildersleve J, Dearnaley DP, Evans PM, Law M, Rawlings C, Swindell W (1994) A randomized trial of patient repositioning during radiotherapy using a megavoltage imaging system. Radiother Oncol 31: 161–168

    Article  PubMed  CAS  Google Scholar 

  • Given RW, Parsosn JT, McCarley D, et al. (1995) Bladder-sparing multimodality treatment of muscle-invasive bladder cancer. A 5-year follow-up. Urol 46: 499–505

    Article  PubMed  CAS  Google Scholar 

  • Gospodarowicz MK, Hawkins MV, Rawling GA, et al. (1989) Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol 142: 1448–1453

    PubMed  CAS  Google Scholar 

  • Gospodarowicz MK, Quilty PM, Scalliet P, et al. (1995) The place of radiation therapy as definitive treatment of bladder cancer. Int J Urol 2: 41–48

    Article  PubMed  Google Scholar 

  • Hall RR (1992) Transurethral resection for transitional cell carcinoma. Urol 6: 460–470

    Google Scholar 

  • Hall RR (1995) Bladder preserving treatment: the role of transurethral surgery alone and with combined modality therapy for muscle-invading bladder cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS (eds) Comprehensive textbook of genitourinary oncology. Williams and Wilkins, Baltimore, pp 509–513

    Google Scholar 

  • Hall RR, Roberts JT (1991) Neoadjuvant chemotherapy, a method to conserve the bladder? ECCO 6:Abstract 144

    Google Scholar 

  • Hall RR, Newling DWW, Ramsden PD, et al. (1984) Treatment of invasive bladder cancer by local resection and high dose methotrexate. Br J Urol 56: 668–672

    Article  PubMed  CAS  Google Scholar 

  • Henry K, Miller J, Mort M, Loening S, Fallon B (1988) Comparison of transurethral resection to radical therapies for stage B bladder tumors. J Urol 140: 964–967

    PubMed  CAS  Google Scholar 

  • Herr HW (1987) Conservative management of muscle-infiltrating bladder cancer: prospective experience. J Urol 138: 1162–1163

    PubMed  CAS  Google Scholar 

  • Horwich A, Pendlebury S, Dearnaley DP (1995) Organ conservation in bladder cancer. Eur J Cancer 31: 208

    Article  Google Scholar 

  • Houssett M, Maulard C, Chretien YC, et al. (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11: 2150–2157

    Google Scholar 

  • Jenkins BJ, Blandy JP, Caulfield MJ, et al. (1988) Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive bladder cancer. Br J Urol 62: 343–346

    Article  PubMed  CAS  Google Scholar 

  • Kachnic LA, Shipley WU, Griffin PP, Zietman AL, Kaufman DS, Althausen AF, Heney NM (1996) Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient. Cancer J Sci Am 2: 79–84

    PubMed  CAS  Google Scholar 

  • Kachnic LA, Kaufman DS, Griffin PP, Heney NM, Althausen AF, Zietman AL, Shipley WU (1997) Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15: 1022–1029

    PubMed  CAS  Google Scholar 

  • Kaufman DS, Shipley WU, Griffin PP, Heney NM, Althausen AF, Efird JT (1993) Selective bladder preservation by combined modality treatment of invasive bladder cancer. N Engl J Med 329: 1377–1382

    Article  PubMed  CAS  Google Scholar 

  • Keating J, Zincke H, Morgan WR, et al. (1989) Extended experience with neoadjuvant M-VAC chemotherapy for invasive transitional cell carcinoma of the urinary bladder. J Urol 141: 244a

    Google Scholar 

  • Koiso K, Shipley WU, Keuppen S, et al. (1995) The status of bladder preserving therapeutic strategies in the management of patients with muscle invasive bladder cancer. Int J Urol 2: 49–57

    Article  PubMed  Google Scholar 

  • Kurth K II, Splinter TA, Jacqmin D, et al. (1991) Transitional cell carcinoma of the bladder: a phase II study of chemotherapy in T3–4 NO MO of the EORTC GU group. In: Alderson AR, Oliver RT, Hanham IW, Bloom HJ (eds) Urological oncology dilemmas and developments. Wiley Liss, New York, pp 115–128

    Google Scholar 

  • Larsen LE, Engelholm SA (1994) The value of 3-dimensional radiotherapy planning in advanced carcinoma of the urinary bladder based on computed tomography. Acta Oncol 33: 655–694

    Article  PubMed  CAS  Google Scholar 

  • Lynch WJ, Jenkins BJ, Fowler CG (1992) The quality of life after radial radiotherapy for bladder cancer. Br J Urol 70: 519–521

    PubMed  CAS  Google Scholar 

  • Maffezzini M, Torelli T, Villa E, et al. (1991) Systemic preoperative chemotherapy with cisplatin, methotrexate, and vinblastine for locally advanced bladder cancer: local tumor response and early follow-up results. J Urol 145: 741–743

    PubMed  CAS  Google Scholar 

  • Mameghan H, Fisher R, Mameghan J, et al. (1995) Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 31: 247–254

    Article  PubMed  CAS  Google Scholar 

  • Marks LB, Shipley WU (1992) Techniques for external irradiation of patients with invasive carcinoma of the urinary Bladder. In: Levitt SH (ed) Technologic: basis of radiotherapy: practical clinical applications, 2nd edn. Lea & Febiger, Philadelphia, chapter 22, pp 335–341

    Google Scholar 

  • Martinez-Pineiro JA, Martin MG, Arocena NF, et al. (1995) Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study. J Urol 153: 964–973

    Article  PubMed  CAS  Google Scholar 

  • Naslund I, Nilsson B, Littbrand B (1994) Hyper-fractionated radiotherapy of bladder cancer: a 10 year follow-up of a randomized clnical trial. Acta Oncol 33: 397–402

    Article  PubMed  CAS  Google Scholar 

  • Parsons JT, Million RR (1991) Bladder cancer. In: Perez CA, Brady IW (eds) Principles and practice of radiation oncology. Lippincott, Philadephia, pp 1036–1058

    Google Scholar 

  • Prout GR, Shipley WU, Kaufman D, et al. (1990) Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy. J Urol 144: 1128–1134

    PubMed  Google Scholar 

  • Quilty P, Duncan W (1986) Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys 12: 853–860.

    Article  PubMed  CAS  Google Scholar 

  • Roberts JT, Fossa SP, Richards SB, et al. (1991) Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladder. Br J Urol 68: 162–168

    Article  PubMed  CAS  Google Scholar 

  • Rothwell R, Ash D, Jones W (1983) Radiation treatment planning for bladder cancer: a comparison of cystogram localization with computed tomography. Clin Radiol 34: 103–111

    Article  PubMed  CAS  Google Scholar 

  • Sauer R, Dunst J, Altendorg-Hofmann A, et al. (1990) Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys 19: 687–691

    Article  PubMed  CAS  Google Scholar 

  • Scher HI, Herr HW, Sternberg C, et al. (1989) Neoadjuvant chemotherapy for invasive bladder cancer. Experience with the MVAC regimen. Br J Urol 64: 250–256

    Article  PubMed  CAS  Google Scholar 

  • Schultz TK, Herr HW, Zhang ZF, et al. (1994) Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival in patients treated with M-VAC with 5-year follow-up. J Clin Oncol 12: 1394–1401

    PubMed  CAS  Google Scholar 

  • Shearer RJ, Chilvers CE, Bloom HJG, et al. (1988) Adjuvant chemotherapy in T3 carcinoma of the bladder. Br J Urol 62: 558–564

    Article  PubMed  CAS  Google Scholar 

  • Shipley WU, Rose MA (1985). Bladder cancer. The selection of patients for treatment of full-dose irradiation. Cancer 55: 2278–2284

    Article  PubMed  CAS  Google Scholar 

  • Shipley WU, Van der Schueren E, Kitagawa T, et al. (1986) Guidelines for radiation therapy in clinical research on bladder cancer. In: Denis L, Niijima T, Prout GR Jr, Schroder FH (eds) Developments in bladder cancer. EORTC Genitourinary Group monograph 3. Liss, New York, pp 109–121

    Google Scholar 

  • Shipley WU, Prout GR Jr, Einstein AB, et al. (1987) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258: 931–935

    Article  PubMed  CAS  Google Scholar 

  • Smaaland R, Akslen LA, Tonder B, et al. (1991) Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. Br J Urol 67: 61–69

    Article  PubMed  CAS  Google Scholar 

  • Srougi M, Simon SD (1994) Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy in bladder preservation in locally invasive bladder cancer: A 5-year follow-up. J Urol 151: 593–597

    PubMed  CAS  Google Scholar 

  • Sternberg CN, Raghaven D, Ohi Y, et al. (1995) Neo-adjuvant and adjuvant chemotherapy in locally advanced disease: what are the effects on survival and prognosis. Int J Urol 2: 75–87

    Article  Google Scholar 

  • Sur RK, Clinkard J, Jones WG et al. (1993) Changes in target volume during radiotherapy treatment of invasive bladder cancer. Clin Oncol 5: 30–33

    Article  CAS  Google Scholar 

  • Tester W, Porter A, Heney J, et al. (1991) Neoadjuvant combined modality program with possible organ preservation for invasive bladder cancer. Proc Am Soc Clin Oncol 10: 165

    Google Scholar 

  • Tester W, Porter A, Asbell S, et al. (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85–12. Int J Radiat Oncol Biol Phys 25: 783–790

    Article  PubMed  CAS  Google Scholar 

  • Tester W, Caplan R, Heaney J, et al. (1996) Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of RTOG phase III trial 8802. J Clin Oncol 14: 119–126

    PubMed  CAS  Google Scholar 

  • Turner S, Swindell R, Bowl N, Read G, Cowan RA (1994) Bladder movement during radiation therapy for bladder cancer: implication for treatment planning. Int J Radiat Oncol Biol Phys 30: 199–200

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Genitourinary Oncology Unit, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, 02114, USA

    W. U. Shipley MD (Head) & A. L. Zietman MD

  2. Medical Oncology Unit, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, 02114, USA

    D. S. Kaufman MD

  3. Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA

    A. F. Althausen MD & N. M. Heney MD

Authors
  1. W. U. Shipley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. L. Zietman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. S. Kaufman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. F. Althausen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. M. Heney MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of Southern California, USC/Norris Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    Zbigniew Petrovich MD, FACR (Professor and Chairman) (Professor and Chairman)

  2. Department of Urology, UZ Gasthuisberg, University of Leuven, Herestraat 49, B-3000, Leuven, Belgium

    Luc Baert MD, PhD (Professor and Chairman) (Professor and Chairman)

  3. Department of Radiation Oncology and Nuclear Medicine, Allegheny University Hospitals, Center City, Mail Stop 200, Broad & Vine Sts., Philadelphia, PA, 19102-1192, USA

    Luther W. Brady MD (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Shipley, W.U., Zietman, A.L., Kaufman, D.S., Althausen, A.F., Heney, N.M. (1998). Bladder-Conserving Therapy for Invasive Bladder Cancer Using Transurethral Surgery, Chemotherapy, and Radiation Therapy with Patient Selection by Initial Treatment Response. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Bladder. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60258-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60258-0_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64323-1

  • Online ISBN: 978-3-642-60258-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation